https://store-images.s-microsoft.com/image/apps.1957.7f7ed746-baae-4942-8263-4c6f6dbd1063.292f2a00-3992-4950-aa2e-84c5833e8dc7.f3e32dc6-7219-433a-863e-6f861eba18c0
AEYE Health Diagnostic Screening
AEYE Health, Inc.
AEYE Health Diagnostic Screening
AEYE Health, Inc.
AEYE Health Diagnostic Screening
AEYE Health, Inc.
Screening diabetics for diabetic retinopathy with AI instead of referring to a specialist
AEYE Diagnostic Screening (AEYE-DS) allows primary care providers to screen their diabetic patients for diabetic retinopathy using AI technology instead of referring them to specialists. AEYE-DS is FDA-cleared based on a large scale clinical study. Screening patients requires a single image per eye, and produces a result instantly and with best-in-class accuracy (Sensitivity 93%; Specificity 91.4%).
AEYE Health provides the only practical AI-based diagnostic screening solution for diabetic retinopathy. The procedure is reimbursable by primary care providers using a dedicated CPT code 92229.
Diabetic retinopathy screenings are required once a year for patients with diabetes. Studies show that less than 50% of patients make their annual screening appointments, which translates into significant care gaps and poor patient outcomes.
Más información
AEYE-DS One Pagerhttps://store-images.s-microsoft.com/image/apps.43724.7f7ed746-baae-4942-8263-4c6f6dbd1063.292f2a00-3992-4950-aa2e-84c5833e8dc7.675aa511-6233-4fcc-9099-7b0e62f8598c
https://store-images.s-microsoft.com/image/apps.43724.7f7ed746-baae-4942-8263-4c6f6dbd1063.292f2a00-3992-4950-aa2e-84c5833e8dc7.675aa511-6233-4fcc-9099-7b0e62f8598c
https://store-images.s-microsoft.com/image/apps.28519.7f7ed746-baae-4942-8263-4c6f6dbd1063.292f2a00-3992-4950-aa2e-84c5833e8dc7.a32174af-5489-4b5e-9445-7070734458cb